id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-N-5192-0014,FDA,FDA-2019-N-5192,"Microbiology Devices; Reclassification
of Human Immunodeficiency Virus
Serological Diagnostic and
Supplemental Tests and Human
Immunodeficiency Virus Nucleic Acid
Diagnostic and Supplemental Tests",Rule,Final Rule,2022-05-16T04:00:00Z,2022,5,2022-05-16T04:00:00Z,,2022-05-16T14:35:27Z,2022-10461,0,0,090000648507f151
FDA-2019-N-5192-0003,FDA,FDA-2019-N-5192,Reference 2 - Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies re: Microbiology Devices; Reclassification of Human Immunodeficiency Virus Serological Diagnostic and Supplemental Tests and Human  Immunodeficiency Virus Nucleic Acid Diagnostic and Supplemental Tests,Supporting & Related Material,Background Material,2020-02-21T05:00:00Z,2020,2,,,2020-02-24T00:07:58Z,,0,0,0900006484399ccf
FDA-2019-N-5192-0004,FDA,FDA-2019-N-5192,Reference 3 - BPAC-07.18.18-07.19.18-Meeting-Issue-Summary-Reclassification-of-HIV-Point-of-Care-and-Laboratory-based-serological-and-NAT-diagnostic-devices re: Microbiology Devices; Reclassification of Human Immunodeficiency Virus Serological Diagnostic and Supplemental Tests and Human  Immunodeficiency Virus Nucleic Acid Diagnostic and Supplemental Tests,Supporting & Related Material,Background Material,2020-02-21T05:00:00Z,2020,2,,,2020-02-24T00:10:37Z,,0,0,0900006484399cd0
FDA-2019-N-5192-0001,FDA,FDA-2019-N-5192,"Microbiology Devices; Reclassification of Human Immunodeficiency Virus
Serological Diagnostic and Supplemental Tests and Human  Immunodeficiency Virus Nucleic Acid Diagnostic and Supplemental Tests",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2020-02-21T05:00:00Z,2020,2,2020-02-21T05:00:00Z,2020-04-22T03:59:59Z,2020-04-22T01:00:35Z,2020-03515,0,0,0900006484397dd6
FDA-2019-N-5192-0002,FDA,FDA-2019-N-5192,"Reference 1 - Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings re: Microbiology Devices; Reclassification of Human Immunodeficiency Virus
Serological Diagnostic and Supplemental Tests and Human  Immunodeficiency Virus Nucleic Acid Diagnostic and Supplemental Tests",Supporting & Related Material,Background Material,2020-02-21T05:00:00Z,2020,2,,,2020-02-24T00:05:31Z,,0,0,0900006484399cce